Medicine and Dentistry
Symptomatic Treatment
100%
Interstitial Lung Disease
95%
Dyspnea
68%
Diseases
66%
Quality of Life
26%
Systematic Review
21%
Chronic Obstructive Pulmonary Disease
20%
Cost-Effectiveness Analysis
16%
Silo-Filler's Disease
16%
Observational Study
15%
Health Status
14%
Needs Assessment
13%
COVID-19
13%
Placebo
12%
Coughing
11%
Numeric Rating Scale
10%
Primary Health Care
10%
Clinician
9%
Idiopathic Pulmonary Fibrosis
9%
Meta-Analysis
9%
Benzodiazepine Derivative
9%
Symptom Management
8%
Randomized Controlled Trial
8%
Forced Vital Capacity
8%
Malignant Neoplasm
7%
Clinical Trial
7%
Patient-Reported Outcome
7%
Mirtazapine
7%
Cohort Analysis
7%
Morphine
7%
Congestive Heart Failure
7%
Respiratory Disease
6%
Randomized Clinical Trial
6%
Progressive Disease
6%
Pooled Analysis
6%
Retrospective Study
6%
Clinical Research
6%
Minimal Clinically Important Difference
6%
Prevalence
6%
Ethnic Minority Group
6%
Rasch Analysis
6%
Patient Experience
6%
Prospective Study
6%
Drug Screening
6%
Patient-Data
6%
Nintedanib
6%
General Practitioner
6%
White Population
6%
Health Care Cost
6%
Chronic Respiratory Questionnaire
5%
Nursing and Health Professions
Palliative Therapy
98%
Interstitial Lung Disease
80%
Diseases
71%
Dyspnea
51%
Systematic Review
21%
Cost Effectiveness Analysis
15%
Health Practitioner
14%
Quality of Life
14%
Obstructive Lung Disease
13%
Confidence Interval
11%
Primary Medical Care
10%
Benzodiazepine Derivative
10%
Numeric Rating Scale
9%
Symptom Management
8%
Malignant Neoplasm
8%
Clinical Practice
8%
Health Status
7%
Coughing
7%
Meta Analysis
7%
Cohort Analysis
7%
Congestive Heart Failure
7%
General Practitioner
6%
Patient Coding
6%
Practice Guideline
6%
Minimal Clinically Important Difference
6%
St. George Respiratory Questionnaire
6%
Forced Vital Capacity
6%
Drug Screening
6%
Ethnic Minority Group
6%
Pandemic
5%
Chronic Respiratory Questionnaire
5%
Patient Care
5%
Pharmacology, Toxicology and Pharmaceutical Science
Dyspnea
59%
Diseases
29%
Interstitial Lung Disease
27%
Chronic Obstructive Lung Disease
21%
Mirtazapine
20%
Placebo
19%
Lung Disease
17%
Fibrosing Alveolitis
13%
Coughing
11%
Clinical Trial
7%
Observational Study
7%
Respiratory Tract Disease
6%
Congestive Heart Failure
6%
Base
6%
Nintedanib
6%
Morphine
6%
Modified Release
6%
Prevalence
6%
Drug Screening
6%
Paracetamol
6%
